cas 28875-17-4|| where to buy N-Boc-L-alanine Methyl Ester

Produktname:N-Boc-L-alanine Methyl Ester

IUPAC Name:methyl (2S)-2-{[(tert-butoxy)carbonyl]amino}propanoate

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM119523-25g	1-2 Weeks	Ƥſ
CM119523-100g	3-4 Weeks	ȌſǠ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 28875-17-4 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:28875-17-4; Molekulare Formel:C9H17NO4; Schmelzpunkt:-; SMILES-Code:C[C@@H](C(OC)=O)NC(OC(C)(C)C)=O; Dichte:

: Katalognummer:CM119523; Molekulargewicht:203.24; Siedepunkt:; Mdl-Nr.:MFCD00038513; Lagerung:

: Amino Acids and Peptides; Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.; amino acids wholesale; if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!

: PF-06648671; The Journal of Medicinal Chemistry recently publishes an article titled, “Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease”. Amyloid β-peptide (Aβ) accumulation is one of the key hallmarks of Alzheimer’s disease (AD). γ-secretase cleaves the amyloid precursor protein (APP) into pathologically relevant Aβs, and has been widely studied as a potential target for the treatment of AD.
Pfizer‘s PF-06648671 is a Gamma secretase modulator (GSM) targeting APP processing. It is found to have excellent central exposure in human and robust reduction of amyloidogenic forms (Aβ42) in cerebrospinal fluid (CSF).